Logo for Xencor Inc

Xencor Investor Relations Material

Latest events

Logo for Xencor Inc

Q4 2023

Xencor
Logo for Xencor

Q1 2024

9 May, 2024
Logo for Xencor

Q4 2023

27 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Xencor Inc

Access all reports
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. Xencor Inc was founded in 1997, and is headquartered in Monrovia, California, United States.